ADR priced at approximately $158.26, with an offering size of about $28.2 billion, making it the largest U.S. listing by a foreign company in history.

Goldman Sachs is bullish on Microsoft, but the earnings report needs to prove that AI spending can translate into cloud revenue.

Foreign capital sell-off, leveraged ETF backlash, a triple crisis ignites the "semiconductor paradox" — megacap earnings surge yet suffer a bloodbath. With tightening cycle pressures mounting, South Korea's capital market is facing a daunting survival test.

There is no eternal "Wild West." Those who find crypto boring should probably turn their attention to AI now.

Goldman Sachs recommends going long on the China AI value chain, betting on the discrepancy between revenue contribution and global fund positioning.

Musk stated that Grok 4.5 is faster and has higher token efficiency, positioning it as an "Opus-level" model.

China's Leading Memory Chip Stock, CXMT, Set for IPO by End of July at the Earliest

Deep squat, then jump! Ultimately, it's the tech giants that determine the bounce power.

Different models show a high degree of consensus on the semi-finalists: France, Spain, England, and Argentina.

Changxin Technology's STAR Market IPO Launches, Estimated Market Cap Nears 295 Billion Yuan, First-Day Lock-up Ratio Reaches 78%.

The Big Three continue burning cash, with Meta's valuation discount being the most glaring

By the end of 2027, its ARR is projected to reach $300 billion, corresponding to a $6 trillion enterprise value. With its IPO application confidentially submitted, the capital showdown with OpenAI has already quietly begun.

From Huawei’s "Genius Teen" to a Controversial Figure in Web3: The Metagent Funding Saga of Li Bojie.

From Meta, CXMT, and South Korea's capacity expansion, to DRAM/NAND prices and cloud capital expenditures, no substantial reversal has occurred in either industry demand or the pace of capacity release.

The rally is driven by two key factors: first, core institutional shareholders have publicly stated their intention to hold long-term, with no signs of a sell-off stampede; second, Wall Street investment banks like JPMorgan and Goldman Sachs are bullish on their commercialization prospects, issuing "overweight" or "buy" ratings, leading to a market value reassessment.

August stock lock-up expiry approaching, what other potential catalysts does SpaceX have?